Status:
COMPLETED
The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Conditions:
Bronchoscopy
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to investigate the feasibility of using balanced propofol sedation for bronchoscopy. And screen out the optimal balanced propofol sedation compatibility plan.
Detailed Description
Balanced propofol sedation (BPS) is a technique proposed and developed by gastroenterologists. In recent years, multiple studies have confirmed that the use of BPS in gastrointestinal endoscopy can no...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists classes I-IV ;
- Patients undergo painless bronchoscopy, including bronchoscopic biopsy (bronchoscopic lesion biopsy, bronchial mucosal biopsy, bronchoscopic transmural lung biopsy, bronchoscopic needle aspiration biopsy) ,bronchoalveolar lavage and bronchoscopic treatment;
- Normal communication skills and able to cooperate in completing this study;
- Patients who voluntarily accept this experimental study and sign the "Trial Informed Consent Form".
Exclusion
- Patients with contraindications or allergies to anesthesia;
- Individuals with a history of alcoholism or drug abuse;
- Patients with contraindications for puncture of the cricoid membrane;
- Patients with mental or neurological disorders, taking anti anxiety/depression drugs, or primary diseases with laboratory evidence indicating possible changes in hormone levels;
- Patients with difficulty in language communication, poor understanding ability, and inability to cooperate in completing experimental studies;
- Patients who require laryngeal mask or tracheal intubation for assisted ventilation during the examination process;
- Patients undergoing rigid bronchoscopy treatment;
- Patients who refuse to receive sedation or have not signed the "Trial Informed Consent Form".
Key Trial Info
Start Date :
September 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT06116955
Start Date
September 21 2023
End Date
January 1 2024
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of Qingdao University
Shandong, Qingdao, China